Peripheral Arterial Disease Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Peripheral Arterial Disease (PAD) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripheral Arterial Disease (PAD) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripheral Arterial Disease (PAD) Therapeutics Overall Market Size
2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size: 2021 VS 2028
2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Peripheral Arterial Disease (PAD) Therapeutics Players in Global Market
3.2 Top Global Peripheral Arterial Disease (PAD) Therapeutics Companies Ranked by Revenue
3.3 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Peripheral Arterial Disease (PAD) Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Peripheral Arterial Disease (PAD) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Peripheral Arterial Disease (PAD) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Peripheral Arterial Disease (PAD) Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Anti-Platelet Drugs
4.1.3 Dual Antiplatelet Therapy Drugs
4.1.4 Others
4.2 By Type - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2017-2028
6.3.2 US Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.3.3 Canada Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.3.4 Mexico Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2017-2028
6.4.2 Germany Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.4.3 France Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.4.4 U.K. Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.4.5 Italy Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.4.6 Russia Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.4.8 Benelux Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2017-2028
6.5.2 China Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.5.3 Japan Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.5.4 South Korea Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.5.6 India Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2017-2028
6.6.2 Brazil Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.6.3 Argentina Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2017-2028
6.7.2 Turkey Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.7.3 Israel Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
6.7.5 UAE Peripheral Arterial Disease (PAD) Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca Plc. (UK)
7.1.1 AstraZeneca Plc. (UK) Corporate Summary
7.1.2 AstraZeneca Plc. (UK) Business Overview
7.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.1.4 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Plc. (UK) Key News
7.2 Bayer HealthCare Pharmaceuticals (Germany)
7.2.1 Bayer HealthCare Pharmaceuticals (Germany) Corporate Summary
7.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
7.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.2.4 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Bayer HealthCare Pharmaceuticals (Germany) Key News
7.3 Bristol-Myers Squibb Company (US)
7.3.1 Bristol-Myers Squibb Company (US) Corporate Summary
7.3.2 Bristol-Myers Squibb Company (US) Business Overview
7.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.3.4 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Bristol-Myers Squibb Company (US) Key News
7.4 Merck & Co., Inc. (US)
7.4.1 Merck & Co., Inc. (US) Corporate Summary
7.4.2 Merck & Co., Inc. (US) Business Overview
7.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.4.4 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Merck & Co., Inc. (US) Key News
7.5 Proteon Therapeutics, Inc. (US)
7.5.1 Proteon Therapeutics, Inc. (US) Corporate Summary
7.5.2 Proteon Therapeutics, Inc. (US) Business Overview
7.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.5.4 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Proteon Therapeutics, Inc. (US) Key News
7.6 Sanofi S.A. (France)
7.6.1 Sanofi S.A. (France) Corporate Summary
7.6.2 Sanofi S.A. (France) Business Overview
7.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.6.4 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Sanofi S.A. (France) Key News
7.7 Symic Bio, Inc. (US)
7.7.1 Symic Bio, Inc. (US) Corporate Summary
7.7.2 Symic Bio, Inc. (US) Business Overview
7.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.7.4 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Symic Bio, Inc. (US) Key News
7.8 TheraVasc Inc. (US)
7.8.1 TheraVasc Inc. (US) Corporate Summary
7.8.2 TheraVasc Inc. (US) Business Overview
7.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.8.4 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.8.5 TheraVasc Inc. (US) Key News
7.9 AnGes MG, Inc. (Japan)
7.9.1 AnGes MG, Inc. (Japan) Corporate Summary
7.9.2 AnGes MG, Inc. (Japan) Business Overview
7.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.9.4 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.9.5 AnGes MG, Inc. (Japan) Key News
7.10 Athersys, Inc. (US)
7.10.1 Athersys, Inc. (US) Corporate Summary
7.10.2 Athersys, Inc. (US) Business Overview
7.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.10.4 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Athersys, Inc. (US) Key News
7.11 Betagenon AB (Sweden)
7.11.1 Betagenon AB (Sweden) Corporate Summary
7.11.2 Betagenon AB (Sweden) Business Overview
7.11.3 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.11.4 Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.11.5 Betagenon AB (Sweden) Key News
7.12 miRagen Therapeutics, Inc. (US)
7.12.1 miRagen Therapeutics, Inc. (US) Corporate Summary
7.12.2 miRagen Therapeutics, Inc. (US) Business Overview
7.12.3 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.12.4 miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.12.5 miRagen Therapeutics, Inc. (US) Key News
7.13 Multi Gene Vascular Systems Ltd (Israel)
7.13.1 Multi Gene Vascular Systems Ltd (Israel) Corporate Summary
7.13.2 Multi Gene Vascular Systems Ltd (Israel) Business Overview
7.13.3 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.13.4 Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.13.5 Multi Gene Vascular Systems Ltd (Israel) Key News
7.14 ViroMed Co. Ltd. (Korea)
7.14.1 ViroMed Co. Ltd. (Korea) Corporate Summary
7.14.2 ViroMed Co. Ltd. (Korea) Business Overview
7.14.3 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Major Product Offerings
7.14.4 ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global Market (2017-2022)
7.14.5 ViroMed Co. Ltd. (Korea) Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Peripheral Arterial Disease (PAD) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Peripheral Arterial Disease (PAD) Therapeutics Market Drivers in Global Market
Table 3. Peripheral Arterial Disease (PAD) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Peripheral Arterial Disease (PAD) Therapeutics in Global Market
Table 5. Top Peripheral Arterial Disease (PAD) Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Peripheral Arterial Disease (PAD) Therapeutics Product Type
Table 9. List of Global Tier 1 Peripheral Arterial Disease (PAD) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Peripheral Arterial Disease (PAD) Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Peripheral Arterial Disease (PAD) Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Plc. (UK) Corporate Summary
Table 31. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 32. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Bayer HealthCare Pharmaceuticals (Germany) Corporate Summary
Table 34. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 35. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Company (US) Corporate Summary
Table 37. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 38. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co., Inc. (US) Corporate Summary
Table 40. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 41. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Proteon Therapeutics, Inc. (US) Corporate Summary
Table 43. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 44. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Sanofi S.A. (France) Corporate Summary
Table 46. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 47. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Symic Bio, Inc. (US) Corporate Summary
Table 49. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 50. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. TheraVasc Inc. (US) Corporate Summary
Table 52. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 53. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. AnGes MG, Inc. (Japan) Corporate Summary
Table 55. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 56. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Athersys, Inc. (US) Corporate Summary
Table 58. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 59. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 60. Betagenon AB (Sweden) Corporate Summary
Table 61. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 62. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 63. miRagen Therapeutics, Inc. (US) Corporate Summary
Table 64. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 65. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 66. Multi Gene Vascular Systems Ltd (Israel) Corporate Summary
Table 67. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 68. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
Table 69. ViroMed Co. Ltd. (Korea) Corporate Summary
Table 70. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Product Offerings
Table 71. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Peripheral Arterial Disease (PAD) Therapeutics Segment by Type in 2021
Figure 2. Peripheral Arterial Disease (PAD) Therapeutics Segment by Application in 2021
Figure 3. Global Peripheral Arterial Disease (PAD) Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Peripheral Arterial Disease (PAD) Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Peripheral Arterial Disease (PAD) Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Therapeutics Revenue in 2021
Figure 8. By Type - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Peripheral Arterial Disease (PAD) Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Peripheral Arterial Disease (PAD) Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Betagenon AB (Sweden) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. miRagen Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Multi Gene Vascular Systems Ltd (Israel) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. ViroMed Co. Ltd. (Korea) Peripheral Arterial Disease (PAD) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
